Fulgent Genetics, Inc.
FLGT
$21.77
$0.3751.75%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 292.93M | 320.32M | 258.11M | 213.07M | 311.71M |
| Total Receivables | 85.04M | 80.44M | 77.03M | 64.90M | 63.72M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 5.33M | 5.74M | 6.63M | 7.07M | 7.29M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 45.44M | 10.28M | 11.81M | 41.51M | 16.39M |
| Total Current Assets | 428.73M | 416.78M | 353.57M | 326.54M | 399.10M |
|
|
|||||
| Total Current Assets | 428.73M | 416.78M | 353.57M | 326.54M | 399.10M |
| Net Property, Plant & Equipment | 115.54M | 112.78M | 111.72M | 113.69M | 103.59M |
| Long-term Investments | 22.06M | 22.06M | 22.06M | 22.06M | 22.06M |
| Goodwill | 22.06M | 22.06M | 22.06M | 22.06M | 22.06M |
| Total Other Intangibles | 131.06M | 133.01M | 134.98M | 137.12M | 138.97M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.98M | 2.08M | 2.37M | 7.21M | 6.92M |
| Total Assets | 1.20B | 1.21B | 1.22B | 1.23B | 1.23B |
|
|
|||||
| Total Accounts Payable | 18.89M | 18.24M | 18.36M | 19.81M | 19.87M |
| Total Accrued Expenses | 20.16M | 15.01M | 22.44M | 21.93M | 23.65M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.02M | 2.16M | 2.25M | 2.34M | 3.19M |
| Total Finance Division Other Current Liabilities | 30.27M | 30.51M | 29.84M | 29.91M | 29.04M |
| Total Other Current Liabilities | 30.27M | 30.51M | 29.84M | 29.91M | 29.04M |
| Total Current Liabilities | 71.34M | 65.92M | 72.90M | 73.99M | 75.75M |
|
|
|||||
| Total Current Liabilities | 71.34M | 65.92M | 72.90M | 73.99M | 75.75M |
| Long-Term Debt | 1.96M | 1.96M | 2.49M | 2.49M | 2.49M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 3.95M | 4.16M | 4.48M | 5.11M | 7.69M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 10.96M | 10.94M | 10.93M | 17.27M | 17.46M |
| Total Liabilities | 88.20M | 82.97M | 90.81M | 98.87M | 103.39M |
|
|
|||||
| Common Stock & APIC | 550.60M | 543.91M | 543.13M | 532.91M | 522.42M |
| Retained Earnings | 559.98M | 578.94M | 590.47M | 596.36M | 611.00M |
| Treasury Stock & Other | 6.00M | 4.34M | -368.00K | 9.18M | -877.00K |
| Total Common Equity | 1.12B | 1.13B | 1.13B | 1.14B | 1.13B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.12B | 1.13B | 1.13B | 1.14B | 1.13B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -4.94M | -4.41M | -4.07M | -3.55M | -3.70M |
| Total Equity | 1.11B | 1.12B | 1.13B | 1.13B | 1.13B |
|
|
|||||